The continued globalization and restructuring of drug development activities demands a new approach to scientific knowledge management, and Centrus finally allows organizations to unlock silos and leverage the information for better decision-making across the value chain.
Phil Reason, Instem CEO
Centrus
- Identify potential safety and efficacy issues early through data mining and analysis
- Find connections between preclinical markers and clinical outcomes to better predict future results
- Expose relationships between chemical structures and preclinical findings to shape candidate drugs earlier
- Draw on historical study data to inform today’s research and development, saving time and money
Links
Accessibility
Contact Us
© 2001 - 2012 Instem Group of Companies - All rights reserved